Contact lens business the Cooper Companies has said it is pleased with its performance so far in 2009.
The eye care products firm increased its revenue from the CooperVision contact lens section by four per cent.
This brought it to $211.2 million.
Its first-quarter profit figures were above those that had been predicted by market estimates.
President and chief executive officer Robert S Weiss said the firm was "very pleased" with the results, especially bearing in mind the economic global slowdown.
He also drew attention to the recent release in Japan of the Proclear 1 Day contact lenses.
Cooper"s biggest acquisition was made in 2005 when it took over Ocular Sciences.
As well as contact lenses, it markets women"s healthcare products and states an interest in "consolidating this highly fragmented market".
CooperVision is its contact lens marketing arm, while CooperSurgical handles marketing for women"s healthcare.
The firm states that it is "committed to improving its market position through product innovation and strategic acquisitions".
by Martin Burns